Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis

JS Alqahtani, T Oyelade, AM Aldhahir, SM Alghamdi… - PloS one, 2020 - journals.plos.org
Background Coronavirus disease 2019 (COVID-19) is an evolving infectious disease that
dramatically spread all over the world in the early part of 2020. No studies have yet …

Defining the relationship between COPD and CVD: what are the implications for clinical practice?

AD Morgan, R Zakeri, JK Quint - Therapeutic advances in …, 2018 - journals.sagepub.com
Cardiovascular diseases (CVDs) are arguably the most important comorbidities in chronic
obstructive pulmonary disease (COPD). CVDs are common in people with COPD, and their …

Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease …

S Safiri, K Carson-Chahhoud, M Noori… - Bmj, 2022 - bmj.com
Objective To report the global, regional, and national burden of chronic obstructive
pulmonary disease (COPD) and its attributable risk factors between 1990 and 2019, by age …

Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide

HC Lai, TL Lin, TW Chen, YL Kuo, CJ Chang, TR Wu… - Gut, 2022 - gut.bmj.com
Objective Chronic obstructive pulmonary disease (COPD) is a global disease characterised
by chronic obstruction of lung airflow interfering with normal breathing. Although the …

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary

CF Vogelmeier, GJ Criner, FJ Martinez… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …

Long-Term PM2.5 Exposure and Respiratory, Cancer, and Cardiovascular Mortality in Older US Adults

VC Pun, F Kazemiparkouhi… - American journal of …, 2017 - academic.oup.com
The impact of chronic exposure to fine particulate matter (particulate matter with an
aerodynamic diameter less than or equal to 2.5 μm (PM2. 5)) on respiratory disease and …

Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised …

J Vestbo, JA Anderson, RD Brook, PMA Calverley… - The Lancet, 2016 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) often coexists with
cardiovascular disease. Treatments for airflow limitation might improve survival and both …

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

J Vestbo, SS Hurd, AG Agustí, PW Jones… - American journal of …, 2013 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is a global health problem, and since 2001,
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …

Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis

F Javanmardi, A Keshavarzi, A Akbari, A Emami… - PloS one, 2020 - journals.plos.org
Introduction Underlying disease have a critical role in vulnerability of populations for a
greater morbidity and mortality when they suffer from COVID-19. The aim of current study is …

Epidemiology and clinical impact of major comorbidities in patients with COPD

MC Smith, JP Wrobel - International journal of chronic obstructive …, 2014 - Taylor & Francis
Comorbidities are frequent in chronic obstructive pulmonary disease (COPD) and
significantly impact on patients' quality of life, exacerbation frequency, and survival. There is …